Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

What does the PANSS mean?

Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR.

Schizophr Res. 2005 Nov 15;79(2-3):231-8.

PMID:
15982856
2.

Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.

Levine SZ, Rabinowitz J, Engel R, Etschel E, Leucht S.

Schizophr Res. 2008 Jan;98(1-3):318-22.

PMID:
17949948
3.

Clinical implications of Brief Psychiatric Rating Scale scores.

Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R.

Br J Psychiatry. 2005 Oct;187:366-71.

4.

Equipercentile linking of the BPRS and the PANSS.

Leucht S, Rothe P, Davis JM, Engel RR.

Eur Neuropsychopharmacol. 2013 Aug;23(8):956-9. doi: 10.1016/j.euroneuro.2012.11.004.

PMID:
23433639
5.

Linking the PANSS, BPRS, and CGI: clinical implications.

Leucht S, Kane JM, Etschel E, Kissling W, Hamann J, Engel RR.

Neuropsychopharmacology. 2006 Oct;31(10):2318-25.

6.

Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.

Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, Cipriani A, Leucht S.

JAMA Psychiatry. 2015 Jan;72(1):14-21. doi: 10.1001/jamapsychiatry.2014.2127.

PMID:
25372935
7.

Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials.

Stauffer V, Case M, Kollack-Walker S, Ascher-Svanum H, Ball T, Kapur S, Kinon BJ.

Schizophr Res. 2011 Aug;130(1-3):11-9. doi: 10.1016/j.schres.2011.03.015. Erratum in: Schizophr Res. 2012 Feb;134(2-3):304.

PMID:
21489754
8.
9.

Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.

Olié JP, Spina E, Murray S, Yang R.

Int Clin Psychopharmacol. 2006 May;21(3):143-51.

PMID:
16528136
10.

Identifying clinically meaningful symptom response cut-off values on the SANS in predominant negative symptoms.

Levine SZ, Leucht S.

Schizophr Res. 2013 Apr;145(1-3):125-7. doi: 10.1016/j.schres.2012.12.032.

PMID:
23394742
11.

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.

J Clin Psychiatry. 2002 Sep;63(9):763-71.

PMID:
12363115
12.
13.

Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.

Bobes J, Arango C, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group..

J Clin Psychiatry. 2010 Mar;71(3):280-6. doi: 10.4088/JCP.08m04250yel. Erratum in: J Clin Psychiatry. 2011 Jul;72(7):1017.

PMID:
19895779
14.

Optimal thresholds of early response to atypical antipsychotics: application of signal detection methods.

Chen L, Ascher-Svanum H, Stauffer V, Kinon BJ, Kollack-Walker S, Ruberg S.

Schizophr Res. 2009 Aug;113(1):34-40. doi: 10.1016/j.schres.2009.06.001.

PMID:
19564097
15.

An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.

Chan HY, Lin AS, Chen KP, Cheng JS, Chen YY, Tsai CJ.

J Clin Psychopharmacol. 2013 Dec;33(6):747-52. doi: 10.1097/JCP.0b013e31829e8168.

PMID:
24100785
16.

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG; Aripiprazole Study Group..

J Clin Psychiatry. 2003 Sep;64(9):1048-56.

PMID:
14628980
17.

[Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].

Bartkó G, Trixler M, Bitter I, Degrell I, Füredi J, Faludi G; Ziprasidonra Váltást Vizsgáló Munkacsoport..

Neuropsychopharmacol Hung. 2006 Dec;8(4):201-9. Hungarian.

PMID:
17211055
18.

To what extent do the PANSS and CGI-S overlap?

Rabinowitz J, Mehnert A, Eerdekens M.

J Clin Psychopharmacol. 2006 Jun;26(3):303-7.

PMID:
16702895
19.
20.

Treatment of acute schizophrenia with paliperidone ER: predictors for treatment response and benzodiazepine use.

Heres S, Don L, Herceg M, Bidzan L, Blanc M, Siracusano A, Maciulis V, Lahaye M, Schreiner A.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:207-12. doi: 10.1016/j.pnpbp.2013.09.015.

PMID:
24096139
Items per page

Supplemental Content

Support Center